New research predicts that healthcare costs will increase by 7% next year. The estimate is higher than the projected medical cost trends in 2022 and 2023 — which were 5.5% and 6.0%, respectively.
In the 12 months leading up to May 15, health services deal volumes decreased just 4% from the year prior, a new report from PwC found. There was a 15% decrease in deal values.
To ensure effective cost mitigation, employers can’t wait for the market to adjust — they have to punch first.
The volume of healthcare deals has increased in 2022, driven in large part by private equity, according to a new PwC report. But deal values have been declining, a trend that is expected to continue into 2023.
As 2020 draws to a close, healthcare providers are strategizing for the new year and the new normal. Providers will need to retool their telehealth efforts and prepare to meet a burgeoning mental crisis, among other issues.
Companies are rolling out suites of tools to monitor their workforce for Covid-19 cases. But even in the midst of a pandemic, there are still limitations on what information they can collect and how they can use it.
Deal value for the third quarter fell sharply from what it was in the first and second quarter, but that was due to the absence of the large acquisitions that took place earlier this year rather than an overall downward trend.
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
The report also found that 56 percent of physicians have brought up the potential for a digital therapy as an option for their patients, and 26 percent have discussed the option after a patient brought it up.
A new software service from the company called Amazon Comprehend Medical uses machine learning and natural language processing to extract relevant medical information from doctors' notes, clinical trial reports and patient health records.
The most recent MoneyTree report from PwC and CB Insights highlights the biggest biotech-related and medical devices VC deals in Q2, which include investments in companies like Grail, Allogene Therapeutics, RefleXion Medical and Mevion Medical Systems.
Experts discuss the multitude of factors feeding high drug prices and some of the solutions that policymakers have proposed.
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
In a panel discussion at MedCity INVEST, a group of health tech professionals and entrepreneurs offered some insight when machine learning algorithms fail to do what they were assigned to do.
PwC partner Greg Vlahos and Matter CEO Steven Collens weighed in on how the biotech and health IT spaces had a great quarter as far as investment dollars are concerned.
A new report from PricewaterhouseCoopers describes the eight technologies that will forever change healthcare over the next decade.
Deregulation, health insurance reform, an aging senior population, and the need to improve access to care, coupled with the rise in smartphone ownership are factors fueling digital health's growth in this Asian nation.
Mega mergers continued to drive M&A deal value higher in the second quarter of the year, but the number of life sciences deals fell from the first quarter of the year, as well as from the same period last year.